Published in Rejuvenation Res on February 01, 2010
Beta2-adrenergic receptor gene polymorphisms as systemic determinants of healthy aging in an evolutionary context. Mech Ageing Dev (2010) 0.92
Unraveling genetic origin of aging-related traits: evolving concepts. Rejuvenation Res (2013) 0.86
Puzzling role of genetic risk factors in human longevity: "risk alleles" as pro-longevity variants. Biogerontology (2015) 0.86
Brain renin-angiotensin system in the nexus of hypertension and aging. Hypertens Res (2012) 0.86
Trade-off in the effect of the APOE gene on the ages at onset of cardiocascular disease and cancer across ages, gender, and human generations. Rejuvenation Res (2013) 0.83
Interactions between social/ behavioral factors and ADRB2 genotypes may be associated with health at advanced ages in China. BMC Geriatr (2013) 0.79
ADRB2 polymorphisms predict the risk of myocardial infarction and coronary artery disease. Genet Mol Biol (2015) 0.79
A Common Polymorphism of the Human Cardiac Sodium Channel Alpha Subunit (SCN5A) Gene Is Associated with Sudden Cardiac Death in Chronic Ischemic Heart Disease. PLoS One (2015) 0.78
Klotho locus, metabolic traits, and serum hemoglobin in hospitalized older patients: a genetic association analysis. Age (Dordr) (2011) 0.78
Angiotensin-converting enzyme (ACE) genotypes and disability in hospitalized older patients. Age (Dordr) (2010) 0.77
Trade-offs in the effects of the apolipoprotein E polymorphism on risks of diseases of the heart, cancer, and neurodegenerative disorders: insights on mechanisms from the Long Life Family Study. Rejuvenation Res (2015) 0.76
How Genes Modulate Patterns of Aging-Related Changes on the Way to 100: Biodemographic Models and Methods in Genetic Analyses of Longitudinal Data. N Am Actuar J (2016) 0.75
Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics (2004) 125.23
Excess deaths associated with underweight, overweight, and obesity. JAMA (2005) 22.17
An investigation of coronary heart disease in families. The Framingham offspring study. Am J Epidemiol (1979) 18.84
A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other. Am J Hum Genet (2004) 14.76
An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest (1990) 10.35
Epistasis--the essential role of gene interactions in the structure and evolution of genetic systems. Nat Rev Genet (2008) 9.26
The Framingham Heart Study 100K SNP genome-wide association study resource: overview of 17 phenotype working group reports. BMC Med Genet (2007) 5.02
Pathway analysis of seven common diseases assessed by genome-wide association. Genomics (2008) 4.11
Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet (1992) 3.33
An evolutionary framework for common diseases: the ancestral-susceptibility model. Trends Genet (2005) 2.92
Trans-ethnic fine mapping of a quantitative trait locus for circulating angiotensin I-converting enzyme (ACE). Hum Mol Genet (2001) 2.75
ACE gene polymorphism in cardiovascular disease: meta-analyses of small and large studies in whites. Arterioscler Thromb Vasc Biol (2000) 1.92
Linkage and association analysis of angiotensin I-converting enzyme (ACE)-gene polymorphisms with ACE concentration and blood pressure. Am J Hum Genet (2001) 1.91
Polymorphisms of the beta2 -adrenoceptor (ADRB2) gene and essential hypertension: the ECTIM and PEGASE studies. J Hypertens (2002) 1.68
Population-based sample reveals gene-gender interactions in blood pressure in White Americans. Hypertension (2006) 1.64
Genetics of the Framingham Heart Study population. Adv Genet (2008) 1.62
Pursuing the longevity dividend: scientific goals for an aging world. Ann N Y Acad Sci (2007) 1.37
Beta2-adrenergic receptor polymorphisms and risk of incident cardiovascular events in the elderly. Circulation (2003) 1.31
Beta-1 and beta-2 adrenoceptor polymorphisms: functional importance, impact on cardiovascular diseases and drug responses. Pharmacol Ther (2007) 1.26
Angiotensin-converting enzyme insertion/deletion gene polymorphic variant as a marker of coronary artery disease: a meta-analysis. Arch Intern Med (2008) 1.19
Marker selection for genetic case-control association studies. Nat Protoc (2009) 1.12
Changing course in ageing research: The healthy ageing phenotype. Maturitas (2009) 1.11
Association between angiotensin-converting enzyme gene polymorphisms and diabetic nephropathy: case-control, haplotype, and family-based study in three European populations. J Am Soc Nephrol (2007) 1.07
Genomic convergence of genome-wide investigations for complex traits. Ann Hum Genet (2009) 1.01
beta(2)-Adrenergic receptor polymorphisms and determinants of cardiovascular risk: the Cardiovascular Health Study. Am J Hypertens (2005) 0.91
A cladistic model of ACE sequence variation with implications for myocardial infarction, Alzheimer disease and obesity. Hum Mol Genet (2004) 0.90
Association of angiotensin-converting enzyme gene 2350G>A polymorphism with myocardial infarction in a Chinese population. Clin Appl Thromb Hemost (2008) 0.89
Association between polymorphisms in the beta2-adrenergic receptor gene with myocardial infarction and ischaemic stroke in women. Thromb Haemost (2009) 0.89
Angiotensin I-converting enzyme: genotype and disease associations. J Mol Diagn (2000) 0.88
ACE (I/D) polymorphism and response to treatment in coronary artery disease: a comprehensive database and meta-analysis involving study quality evaluation. BMC Med Genet (2009) 0.84
An angiotensin converting enzyme haplotype predicts survival in patients with end stage renal disease. Hum Genet (2006) 0.83
Statins, ACE inhibitors and ARBs in cardiovascular disease. Best Pract Res Clin Endocrinol Metab (2009) 0.82
The E27 beta2-adrenergic receptor polymorphism reduces the risk of myocardial infarction in dyslipidemic young males. Thromb Haemost (2001) 0.82
Phenotype-genotype association grid: a convenient method for summarizing multiple association analyses. BMC Genet (2006) 0.80
Primary prevention of heart failure: what is the evidence? Curr Opin Cardiol (2009) 0.79
Frequency of compound genotypes associated with beta-blocker efficacy in congestive heart failure. Pharmacogenomics (2004) 0.79
Cumulative deficits better characterize susceptibility to death in elderly people than phenotypic frailty: lessons from the Cardiovascular Health Study. J Am Geriatr Soc (2008) 2.94
Health and function of participants in the Long Life Family Study: A comparison with other cohorts. Aging (Albany NY) (2011) 1.74
Accumulation of health disorders as a systemic measure of aging: Findings from the NLTCS data. Mech Ageing Dev (2006) 1.74
Cumulative index of health deficiencies as a characteristic of long life. J Am Geriatr Soc (2007) 1.68
Stochastic model for analysis of longitudinal data on aging and mortality. Math Biosci (2006) 1.61
Variability in the treatment of elderly patients with stage IIIA (N2) non-small-cell lung cancer. J Thorac Oncol (2013) 1.53
Cumulative index of elderly disorders and its dynamic contribution to mortality and longevity. Rejuvenation Res (2007) 1.53
Trends in survival and recovery from stroke: evidence from the National Long-Term Care Survey/Medicare data. Stroke (2010) 1.50
A bivariate frailty model with a cure fraction for modeling familial correlations in diseases. Biometrics (2003) 1.46
Health decline, aging and mortality: how are they related? Biogerontology (2007) 1.45
The association of childhood socioeconomic conditions with healthy longevity at the oldest-old ages in China. Demography (2007) 1.44
Visualizing hidden heterogeneity in isogenic populations of C. elegans. Exp Gerontol (2006) 1.33
Accelerated accumulation of health deficits as a characteristic of aging. Exp Gerontol (2007) 1.29
Cancer in rodents: does it tell us about cancer in humans? Nat Rev Cancer (2005) 1.27
Stress resistance declines with age: analysis of data from a survival experiment with Drosophila melanogaster. Biogerontology (2004) 1.25
Insights on aging and exceptional longevity from longitudinal data: novel findings from the Framingham Heart Study. Age (Dordr) (2006) 1.24
Heritability estimates of endophenotypes of long and health life: the Long Life Family Study. J Gerontol A Biol Sci Med Sci (2010) 1.22
Cumulative deficits and physiological indices as predictors of mortality and long life. J Gerontol A Biol Sci Med Sci (2008) 1.20
Insulin and longevity: antidiabetic biguanides as geroprotectors. Biogerontology (2003) 1.17
Age trajectories of physiological indices in relation to healthy life course. Mech Ageing Dev (2011) 1.17
Joint influence of small-effect genetic variants on human longevity. Aging (Albany NY) (2010) 1.16
Body mass index and nine-year mortality in disabled and nondisabled older U.S. individuals. J Am Geriatr Soc (2007) 1.16
Trade-off between cancer and aging: what role do other diseases play? Evidence from experimental and human population studies. Mech Ageing Dev (2008) 1.10
The heritability of CHD mortality in danish twins after controlling for smoking and BMI. Twin Res Hum Genet (2005) 1.09
Exceptional survivors have lower age trajectories of blood glucose: lessons from longitudinal data. Biogerontology (2009) 1.07
Maintaining physiological state for exceptional survival: What is the normal level of blood glucose and does it change with age? Mech Ageing Dev (2009) 1.07
What age trajectories of cumulative deficits and medical costs tell us about individual aging and mortality risk: Findings from the NLTCS-Medicare data. Mech Ageing Dev (2008) 1.06
The role of lipid-related genes, aging-related processes, and environment in healthspan. Aging Cell (2013) 1.05
New age patterns of survival improvement in Sweden: do they characterize changes in individual aging? Mech Ageing Dev (2002) 1.05
Heterogeneity in the Strehler-Mildvan general theory of mortality and aging. Demography (2011) 1.05
Genetic model for longitudinal studies of aging, health, and longevity and its potential application to incomplete data. J Theor Biol (2009) 1.04
Trade-off in the effects of the apolipoprotein E polymorphism on the ages at onset of CVD and cancer influences human lifespan. Aging Cell (2011) 1.03
Diverse trajectories of cocaine use through early adulthood among rebellious and socially conforming youth. Soc Sci Res (2004) 1.03
Model of hidden heterogeneity in longitudinal data. Theor Popul Biol (2007) 1.03
Individual aging and mortality rate: how are they related? Soc Biol (2003) 1.03
What evidence is there for the existence of individual genes with antagonistic pleiotropic effects? Mech Ageing Dev (2005) 1.03
Association between APOE epsilon 2/epsilon 3/epsilon 4 polymorphism and disability severity in a national long-term care survey sample. Age Ageing (2008) 1.03
Leukocyte telomere length is associated with disability in older u.s. Population. J Am Geriatr Soc (2010) 1.02
"Predicting" parental longevity from offspring endophenotypes: data from the Long Life Family Study (LLFS). Mech Ageing Dev (2010) 1.01
Trade-offs between cancer and other diseases: do they exist and influence longevity? Rejuvenation Res (2010) 0.98
What fecundity patterns indicate about aging and longevity: insights from Drosophila studies. J Gerontol A Biol Sci Med Sci (2003) 0.98
Does surgery improve outcomes for esophageal squamous cell carcinoma? An analysis using the surveillance epidemiology and end results registry from 1998 to 2008. J Am Coll Surg (2012) 0.97
Sex-specific health deterioration and mortality: the morbidity-mortality paradox over age and time. Exp Gerontol (2008) 0.96
Adjusting period tempo changes with an extension of Ryder's basic translation equation. Demography (2002) 0.95
Individual fecundity and senescence in Drosophila and medfly. J Gerontol A Biol Sci Med Sci (2005) 0.95
The accuracy of statistical estimates in genetic studies of aging can be significantly improved. Biogerontology (2006) 0.94